Related Experiment Video

Updated: Aug 5, 2025

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on: October 20, 2022

2.3K

Targeting RIPK1 kinase for modulating inflammation in human diseases

Wanjin Li1, Junying Yuan1

  • 1Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.

Frontiers in Immunology
|March 27, 2023
PubMed

Insights

Receptor-Interacting Serine/Threonine-Protein Kinase 1 (RIPK1) kinase promotes inflammation and is implicated in neurodegenerative diseases. Targeting RIPK1 kinase offers a potential therapeutic strategy for inflammatory pathologies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Receptor-Interacting Serine/Threonine-Protein Kinase 1 (RIPK1) regulates TNFR1 signaling, impacting cell death and survival.
  • RIPK1 kinase activation drives necroptosis, apoptosis, and inflammation via cytokine induction.
  • Nuclear translocation of RIPK1 interacts with the BAF complex, influencing chromatin remodeling and transcription.

Purpose of the Study:

  • To review the proinflammatory role of RIPK1 kinase.
  • To focus on the involvement of RIPK1 in human neurodegenerative diseases.
  • To explore RIPK1 kinase as a therapeutic target for inflammatory diseases.

Main Methods:

  • Literature review of RIPK1 signaling pathways.
  • Analysis of RIPK1's role in cell death and inflammatory responses.
  • Examination of RIPK1's involvement in neurodegenerative disease pathogenesis.

Main Results:

  • RIPK1 kinase activation is a key mediator of inflammatory responses.
  • RIPK1 plays a significant role in the pathology of human neurodegenerative diseases.
  • Evidence supports RIPK1's involvement in chromatin remodeling and transcriptional regulation.

Conclusions:

  • RIPK1 kinase is a critical driver of inflammation with implications for neurodegeneration.
  • Targeting RIPK1 kinase presents a promising therapeutic avenue for inflammatory conditions.
  • Further research into RIPK1 modulation is warranted for treating neurodegenerative disorders.
Keywords:
RIPK1apoptosiscaspasechromatin remodelinginflammationnecroptosis

More Related Videos

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

10.9K
Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.2K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K